Advertisement
Person › Details
Mike Romanos (Microbiotica Ltd.)
Romanos, Mike (Microbiotica 201612– CEO + Co-Founder before Crescendo Biologics CEO before CSO before GSK)
Organisation | Microbiotica Ltd. | |
Former/major organisation | Crescendo Biologics Ltd. | |
Product | microbiomic treatment (live biotherapeutic product, LBP) | |
Product 2 | microbiomics | |
Record changed: 2023-07-25 |
Advertisement
More documents for Mike Romanos
- [1] NK:IO Ltd.. (7/25/23). "Press Release: NK:IO Raises £1.2M, Bringing Total Seed Funding to £5.1M, to Advance Pioneering NK Cell Therapy". London....
- [2] NK:IO Ltd.. (7/11/23). "Press Release: Imperial Spinout NK:IO Awarded £1.6M Innovate UK New Cancer Therapeutics Grant for Development of Pioneering NK Cell Therapy". London....
- [3] Microbiotica Ltd.. (3/7/22). "Press Release: Microbiotica Raises £50 Million ($67 Million) to Advance Pipeline of Microbiome-based Therapeutics". Cambridge....
- [4] Microbiotica Ltd.. (10/24/18). "Press Release: Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital Fund". Cambridge....
- [5] Microbiotica Ltd.. (6/6/18). "Press Release: Microbiotica Enters into Microbiome Collaboration with Genentech". Cambridge....
- [6] Microbiotica Ltd.. (5/9/17). "Press Release: Microbiotica Appoints John Shields as Non-Executive Director"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top